STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines

Roche, a leading pharmaceutical company, has signed a drug discovery deal with Chinese biotech Defand Therapeutics. The collaboration focuses on developing molecular glue medicines, a novel approach in drug discovery.

While this is significant news in the pharmaceutical industry, it may not directly impact seafarers.